Crown Laboratories - About the company
Crown Laboratories is an acquired company based in Johnson City (United States), founded in 2000. It operates as a Manufacturer of OTC, prescription, skin care and oral care products. Crown Laboratories has raised an undisclosed amount in funding from Greenspring Associates and Montreux Equity Partners, with last known valuation of $*****. The company has 1394 active competitors, including 53 funded and 205 that have exited. Its top competitors include companies like Famar, Encube Ethicals and Gland Pharma.
Company Details
Crown Laboratories is a manufacturer of OTC, prescription, skin care, and oral care products. Its prescription portfolio includes key branded products AlaScalp, AlaQuin, Daxbia and Dermasorb. The company offers development and manufacturing services for liquid, semi-solid & gel-based products. The company acquired Vita Liberata, an Ireland-based company specializing in sunless tanning and skincare products.
- Website
- crownlaboratories.com
- Email ID
- *****@crownlaboratories.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2000
Location
Johnson City, United States
Stage
Acquired
Latest Funding Round
Last Known Valuation
$***** as on Aug 01, 2024
Investors
Ranked
52nd among 1394 active competitors
Employee Count
443 as on Sep 30, 2026
Investment & Acquisitions
Exit Details
Acquired by Hildred (Oct 30, 2017)
Crown Laboratories's acquisition details
Crown Laboratories got acquired by Hildred on Oct 30, 2017.
Click here to take a look at Crown Laboratories's acquisition in detail
Sign up to download Crown Laboratories' company profile
Crown Laboratories's funding and investors
Crown Laboratories has raised funding over 3 rounds. Its first funding round was on Sep 2015. Its latest funding round was a PE round on May 01, 2019 for $*****. 3 investors participated in its latest round. Crown Laboratories has 5 institutional investors.
Here is the list of recent funding rounds of Crown Laboratories:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 01, 2019 | 7529970 | PE | 9231886 | 5837849 | 8961725 | 4810733 |
Sep 2018 | 8738851 | PE | 4878908 | 8121953 | 9950822 | |
Sep 2015 | 7291022 | Conventional Debt | 6558642 | 2792541 | 9604614 |
View details of Crown Laboratories's funding rounds and investors
Crown Laboratories' founders and board of directors
Founder? Claim ProfileCrown Laboratories' employee count trend
Crown Laboratories has 443 employees as of Sep 26. Here is Crown Laboratories's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Crown Laboratories's Competitors and alternates
Top competitors of Crown Laboratories include Famar, Encube Ethicals and Gland Pharma. Here is the list of Top 10 competitors of Crown Laboratories, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Contract manufacturing and development services provider | $6.06M | 66/100 | ||
2nd | Encube Ethicals 1998, Mumbai (India), Series D | Company offering contract development and manufacturing services for topical semisolid formulations | $65.5M | 64/100 | |
3rd | Gland Pharma 1978, Hyderabad (India), Public | Manufacturer of generic injectable drug | $209M | 63/100 | |
4th | Maiva Pharma 1996, Hosur (India), Series A | Manufacturer of sterile injectables | $133M | 61/100 | |
5th | Luoxin Pharmaceutical Group 2006, Linyi (China), Acquired | Developer and manufacturer of pharmaceutical products | $301M | 61/100 | |
6th | Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired | Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution | $31M | 60/100 | |
7th | Jubilant Life Sciences 1978, Noida (India), Public | Company offering a suite of R&D and manufacturing services for small molecules and generics | - | 59/100 | |
8th | Provider of regulatory affair, quality control, and market strategy services to biopharma sector | $13M | 59/100 | ||
9th | INCOG BioPharma Services 2020, United States, Series C | CDMO focused on manufacturer of injectable drug product | $86.6M | - | 57/100 |
10th | Asahi Kasei 1931, Chiyoda-ku (Japan), Public | CDMO focused on manufacturing of liquid, solid & injectable drug formulations | - | 55/100 | |
52nd | Crown Laboratories 2000, Johnson City (United States), Acquired | Manufacturer of OTC, prescription, skin care and oral care products | - | 47/100 |
Looking for more details on Crown Laboratories's competitors? Click here to see the top ones
Crown Laboratories's Investments and acquisitions
Crown Laboratories has not made any investments yet. Crown Laboratories has made 13 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Feb 08, 2025 | Acquisition | 2002 | Newark (United States) | |
Aug 18, 2022 | Acquisition | 1993 | The Colony (United States) | |
Aug 26, 2021 | Acquisition | 2002 | New York City (United States) |
See all acquisitions by Crown Laboratories
Reports related to Crown Laboratories
Here is the latest report on Crown Laboratories's sector:
News related to Crown Laboratories
•
PanOxyl® BPO Acne Treatment Bar Wins Coveted Allure Best of Beauty AwardPR Newswire•Sep 16, 2025•PanOxyl, Crown Laboratories
•
Crown Laboratories Announces PanOxyl® Acne Wash is #1 Selling Acne Wash in CanadaCNW•Sep 02, 2025•Crown Laboratories
•
Revance Emerges From Crown Labs Merger to Challenge Aesthetic Medicine Giantshttps://www.beautyindependent.com/•Jun 02, 2025•Revance Therapeutics, Crown Laboratories
•
Crown Laboratories and Revance Therapeutics unite as REVANCE offering wide range of solutionsRevance Holdings•May 31, 2025•Revance Therapeutics, Crown Laboratories
•
Crown Laboratories Announces Launch of New Sarna® Eczema Relief Skin Protectant LotionPR Newswire•Mar 27, 2025•Crown Laboratories
•
Strivectin® expands its Peptide Plump™ skincare line with a new collagen cream.PR Newswire•Feb 11, 2025•Crown Laboratories, StriVectin
•
Crown Laboratories Completes Acquisition of Revance TherapeuticsBakersfield•Feb 08, 2025•Crown Laboratories, Revance Therapeutics, Crown
•
Revance, Crown near deal close after earlier bidding warEndPoints News•Feb 06, 2025•Revance Therapeutics, Crown Laboratories
•
Revance (RVNC) investors who lost money: Join a class action lawsuit; contact Levi & Korsinsky.PR Newswire•Jan 24, 2025•Levi & Korsinsky, Revance Therapeutics, Crown Laboratories
•
Crown Laboratories hikes offer price for Revance to $3.65/share, extends existing tender offerSeeking Alpha•Jan 21, 2025•Crown Laboratories, Revance Therapeutics
Are you a Founder ?
FAQs about Crown Laboratories
Explore our recently published companies
- Lacy And Par - Tukwila based, 1984 founded, Unfunded company
- Moeheat - Santa Clarita based, 2008 founded, Public company
- Z-axis Prints - Spokane based, 2010 founded, Unfunded company
- Zen Creative Group - Portland based, 1995 founded, Unfunded company
- Rjo Ventures - North Miami Beach based, 2011 founded, Unfunded company
- Roberts Design - Las Vegas based, 2014 founded, Unfunded company